Insmed INSM 深 沪
已收盘 10-31 16:00:00 美东时间
189.60
-4.620
-2.38%
华盛通- 最 高197.08
- 今 开194.57
- 成交量 315.61万股
- 最 低 187.02
- 昨 收 194.22
- 总市值 400.06亿
- 52周最高 197.08
- 市盈率 静 --
- 换手率 1.50%
- 52周最低 60.40
- 委 比 -63.24%
- 总股本 2.11亿
- 历史最高 197.08
- 量 比 1.19
- 振 幅 5.18%
- 历史最低 2.64
- 每 手 1
- 风险率 31.64%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多UBS Maintains Buy on Insmed, Raises Price Target to $223
UBS analyst Trung Huynh maintains Insmed (NASDAQ:INSM) with a Buy and raises the price target from $194 to $223.
10-31 23:50
快讯 | Insmed Inc：摩根士丹利将目标价从144.00美元上调至158.00美元
Insmed Inc : Morgan Stanley Raises Target Price to $158.00 From $144.00
10-31 18:52
快讯 | Insmed Incorporated：富国银行将目标价从171美元上调至217美元
Insmed Incorporated : Wells Fargo Raises Target Price to $217 From $171
10-31 18:31
4 Stocks To Buy As Precious Metals Soar
The massive rally in gold hit its first significant pullback in months last wee...
10-31 01:41
Insmed outlines $420M-$430M ARIKAYCE revenue target as BRINSUPRI launch gains traction
Earnings Call Insights: Insmed Incorporated (INSM) Q3 2025 Management View William Lewis, President, CEO & Chairman, opened the call noting, "I'm enormously pleased to welcome all of you to Insmed's f...
10-30 23:17
Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big Stocks Moving Higher On Thursday
U.S. stocks were mixed, with the Dow Jones index gaining around 200 points on T...
10-30 22:19
财报速睇 | INSMED Inc 2025财年Q3营收1.42亿美元，股权持有人应占亏损3.70亿美元
华盛资讯10月30日讯，INSMED Inc公司今日公布2025财年Q3业绩，公司Q3营收1.42亿美元，同比增长52.4%，股权持有人应占亏损3.70亿美元，同比亏损扩大67.8%。
10-30 19:24
Earnings Scheduled For October 30, 2025
Companies Reporting Before The Bell • Altria Group (NYSE:MO) is projected to re...
10-30 19:12
Insmed Raises FY2025 Global ARIKAYCE Sales Guidance from $405M-$425M to $420M-$430M
Balance Sheet, Financial Guidance, and Planned InvestmentsAs of September 30, 2025, Insmed had cash, cash equivalents, and marketable securities totaling approximately $1.7 billion.Insmed is raising its full-year 2025
10-30 19:06
Insmed Q3 EPS $(1.75) Misses $(1.38) Estimate, Sales $142.342M Beat $115.604M Estimate
Insmed (NASDAQ:INSM) reported quarterly losses of $(1.75) per share which missed the analyst consensus estimate of $(1.38) by 27.18 percent. This is a 37.8 percent decrease over losses of $(1.27) per share from the same
10-30 19:03
